Immune-mediated hemolytic anemia leads to the premature removal of erythrocytes. It is a type 2 hypersensitivity reaction in which erythrocytes are covered by antibodies or complement and are phagocytized in the spleen or lysed within the blood vessels. It is considered of primary origin when the causes of the onset of the disease are unknown, or regarded as secondary when resulting from external antigens. The diagnosis may be therapeutic or based on the direct positive Coombs test in conjunction with laboratory findings, such as moderate to severe variable regeneration anemia, polychromasia, spherocytosis, red blood cell agglutination, hyperbilirubinemia, and hemoglobinuria. Treatment is based on immunosuppressive doses of steroidal anti-inflammatory drugs such as prednisone. This paper reports the case of an acute onset in a dog diagnosed with primary immune-mediated hemolytic anemia, presenting apathy, dyspnea, pain upon abdominal palpation, splenomegaly and pale mucous membranes. Coombs direct test was positive. Treatment started with prednisone, but as the response was not favorable, other drugs were associated to it. Evolution was unfavorable and the owner opted for euthanasia due to poor prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.